At the 2016 Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), held in Valencia, Spain, Antonio Pagliuca, MD from King’s College Hospital, London, UK discusses the history of veno-occlusive disease (VOD) and defibrotide, which was developed to improve survival rates of patients affected by this devastating condition.